Literature DB >> 6966547

Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.

J W Quin, J A Charlesworth, C H Lee, G J Macdonald.   

Abstract

Fifty sera from twenty-five patients with uncomplicated infectious mononucleosis (IM) were tested for lymphocytotoxic activity (LCA) against pools of lymphocytes collected from (a) normal donors (b) ten patients during the acute phase of IM and (c) four of these patients during the convalescent phase. The LCA of twenty-four sera from patients with systemic lupus erythematosus (SLE) was also tested against the same panels of cells. The percentage of acute phase lymphocytes killed by sera from patients with IM or SLE was significantly less (P less than 0.001 and P less than 0.05 respectively) than the percentage of normal or convalescent cells killed by the same sera. This reduction could not be explained by lymphocyte donor variation as the same donors were used in the acute and convalescent phases of IM. It is suggested that changes in the surface characteristics of acute IM lymphocytes cause a temporary failure of interaction with circulating lymphocytotoxins. Such a phenomenon could have important influences on the self-limiting nature of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966547      PMCID: PMC1538144     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.

Authors:  E Svedmyr; M Jondal
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  Loss of Fc receptors for IgG from human T lymphocytes exposed to IgG immune complexes.

Authors:  L Moretta; M C Mingari; C A Romanzi
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.

Authors:  B F Haynes; R T Schooley; J E Grouse; C R Payling-Wright; R Dolin; A S Fauci
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

4.  The dynamic state of the lymphocyte membrane. Factors affecting the distribution and turnover of surface immunoglobulins.

Authors:  F Loor; L Forni; B Pernis
Journal:  Eur J Immunol       Date:  1972-06       Impact factor: 5.532

5.  Thymic origin of atypical lymphoid cells in infectious mononucleosis.

Authors:  P J Sheldon; E H Hemsted; M Papamichail; E J Holborow
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

6.  Distribution of immunoglobulin on the surface of mouse lymphoid cells as determined by immunoferritin electron microscopy. Antibody-induced, temperature-dependent redistribution and its implications for membrane structure.

Authors:  S de Petris; M C Raff
Journal:  Eur J Immunol       Date:  1972-12       Impact factor: 5.532

7.  Complement, lymphocytotoxins and immune complexes in infectious mononucleosis: serial studies in uncomplicated cases.

Authors:  J A Charlesworth; J W Quin; G J Macdonald; R J Lennane; C R Boughton
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

8.  Ultrastructural, cytochemical, and membrane surface marker characteristics of the atypical lymphocytes in infectious mononucleosis.

Authors:  R W McKenna; J Parkin; K J Gajl-Peczalska; J H Kersey; R D Brunning
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

9.  Antibody-associated lymphotoxin in acute infection.

Authors:  S W Huang; D B Lattos; D B Nelson; K Reeb; R Hong
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.

Authors:  M Jondal; G Klein
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  4 in total

1.  Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes.

Authors:  J A Charlesworth; P Peake; L V Campbell; J Rumma; B A Pussell; N Howard; G J Elder
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

2.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Lymphocytotoxins in infectious mononucleosis: a non-cytotoxic effect on lymphocytes at 37 degrees C and the influence of cell metabolism on their cytotoxicity in vitro.

Authors:  J W Quin; J A Charlesworth; D Yasmeen; G J Macdonald; B A Pussell
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

4.  Normal human serum inhibits the lymphocytotoxicity of sera from patients with infectious mononucleosis.

Authors:  P Peake; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.